Marie O'Donnell

Edinburgh Urological Cancer Group

University of Edinburgh

BIOGRAPHY

Marie O'Donnell has not added Biography.

If you are Marie O'Donnell and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.

The Journal of pathology Mar, 2002 | Pubmed ID: 11857492

Renal scarring caused by vesicoureteric reflux and urinary infection: a study in pigs.

Pediatric nephrology (Berlin, Germany) Jul, 2002 | Pubmed ID: 12172758

Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.

Current biology : CB Mar, 2007 | Pubmed ID: 17306544

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.

EMBO reports Sep, 2008 | Pubmed ID: 18636086

Chronicles of a death foretold: dual sequential cell death checkpoints in TNF signaling.

Cell cycle (Georgetown, Tex.) Mar, 2010 | Pubmed ID: 20237426

RIP1 comes back to life as a cell death regulator in TNFR1 signaling.

The FEBS journal Apr, 2011 | Pubmed ID: 21232018

Caspase 8 inhibits programmed necrosis by processing CYLD.

Nature cell biology Dec, 2011 | Pubmed ID: 22037414

NFÎºB and ubiquitination: partners in disarming RIPK1-mediated cell death.

Immunologic research Dec, 2012 | Pubmed ID: 22477525

NEMO inhibits programmed necrosis in an NFÎºB-independent manner by restraining RIP1.

PloS one , 2012 | Pubmed ID: 22848449

Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer.

PloS one , 2012 | Pubmed ID: 22880013

Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study.

The Journal of urology Sep, 2012 | Pubmed ID: 22999998

INSTITUTIONS

University of Edinburgh

Western General Hospital

JOVE ARTICLES

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Fiach C. O'Mahony¹,

Jyoti Nanda¹,

Alexander Laird¹,

Peter Mullen²,

Helen Caldwell³,

Ian M. Overton⁴,

Lel Eory⁴,

Marie O'Donnell^1,5,

Dana Faratian⁶,

Thomas Powles⁷,

David J. Harrison^1,2,

Grant D. Stewart¹

¹Edinburgh Urological Cancer Group, University of Edinburgh,

²School of Medicine, University of St Andrews,

³Division of Pathology, University of Edinburgh,

⁴MRC Human Genetics Unit, MRC IGMM, University of Edinburgh,

⁵Department of Pathology, Western General Hospital,

⁶Breakthrough Breast Cancer Research Unit, University of Edinburgh,

⁷St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London

Medicine

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center
JoVE Sitemap

Marie O'Donnell

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Edinburgh Urological Cancer Group

University of Edinburgh

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Edinburgh Urological Cancer Group